DAYANG BIOTECH
00301720.722.42% ( +0.49 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: DAYANG BIOTECH(003017) the Revenue is 278.13 M (+11.71%);the EBIT is 34.9 M (+10.48%);the EPS is 0.317 (+5.57%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.28B11.71%
----
----
EBIT
0.03B10.48%
----
----
EPS
0.31675.57%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf